Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes

Abstract

Closed-loop trials in humans should be preceded and concurrently guided by highly efficient and resource-saving computer-based simulations. We demonstrate validity of population-based predictions obtained with our simulation environment.